NCT00763217
Completed
Not Applicable
Characterization of Clinical, Biological and Pharmacological Markers of Stroke Outcome
University Hospital, Lille1 site in 1 country550 target enrollmentJune 2005
ConditionsStroke
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- University Hospital, Lille
- Enrollment
- 550
- Locations
- 1
- Primary Endpoint
- severity of stroke measured by NIH severity score
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
In a previous suty, we have demonstrated that prior transient ischemic attack, treatment lipid-lowering drug or physical activity are associated to a better outcome of stroke. The aim of the study is to understand the mechanisms of this preventive neuroprotection by establishing link between biomarkers and preventive and neuroprotective measures.To answer to the question, we conduct a cohort study of stroke patients.
Detailed Description
In the cohort, the severity of stroke (NIHSS) will be correlated with : * clinical factors, * pharmacological factors, * biological factors (inflammatory markers, hemostasis...)
Investigators
Eligibility Criteria
Inclusion Criteria
- •ischemic or hemorrhage stroke
- •hemispheric stroke
- •stroke dating from less 48h
Exclusion Criteria
- •non hemispheric stroke
- •malformative intracranial hemorrhage
- •traumatic intracranial hemorrhage
- •subarachnoidal hemorrhage
Outcomes
Primary Outcomes
severity of stroke measured by NIH severity score
Time Frame: inclusion, day7, month3, year3
Secondary Outcomes
- clinical, pharmacological and biological (metabolic, inflammation, hemostasis...) cognitive status(inclusion and year3)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Vascular Basis for the Treatment of IschemiaCardiovascular DiseasesHeart DiseasesCoronary DiseaseNCT00005681National Heart, Lung, and Blood Institute (NHLBI)
Completed
Phase 4
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)Coronary Artery DiseaseHyperlipidemiaNCT01023607Harbin Medical University120
Terminated
Not Applicable
Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)Coronary Artery DiseaseNCT01190072AstraZeneca120
Terminated
Phase 4
Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial LipemiaAtherosclerosisHypercholesterolemiaPost Prandial LipemiaCardiovascular DiseasesNCT03559309Medical University of Graz24
Unknown
Not Applicable
Therapeutic Effect of Intravascular Laser Irradiation of BloodLow-Level Laser TherapyNCT03724799Tri-Service General Hospital12